• Bifidobacterium breve BB077 (LMG P-30157)

Bifidobacterium breve BB077 (LMG P-30157)

Overview

Bifidobacterium breve BB077 (LMG P-30157), developed by SynBalance.
Gastrointestinal Health • Cognitive function• Immune prevention

Scientific reference(s)

Additional info

Therapeutical area(s)

Gastrointestinal tract · Gut brain Axis

Functionality

Anti-inflammatory activity · Lactose digestion

Age/Gender

Adults
Search strain on Pubmed

Bifidobacterium breve BB077 (LMG P-30157) is available at

SynBalance SRL
Probiotics, LBPs, prebiotics & postbiotics + Production & Manufacturing

Probiotic blends with Bifidobacterium breve BB077 (LMG P-30157)

AllergAway
KeepCalm
Microbiome Post
MicrobiomePost
Microbiomehub
MicrobiomeHUB
Follow us
Linkedin X-twitter Facebook-f
© 2016-2025 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Scroll to Top